Towards Healthcare
Gene Overexpression Cell Line Construction Service Market to Grow USD 1,629.93...

Gene Overexpression Cell Line Construction Service Market Driven by CRO Demand

According to market projections, the global gene overexpression cell line construction market, valued at USD 788.63 million in 2024, is anticipated to reach USD 1,629.93 million by 2034, growing at a CAGR of 7.53% over the next decade. The versatility of an overexpression research tool makes it popular among wild-type and mutant research. North America dominated the market in 2024, driven by a strong biopharmaceutical and research infrastructure.

  • Insight Code: 6093
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

The gene overexpression cell line construction market stands at USD 848.01 million in 2025 and is expected to reach USD 1,629.93 million by 2034, growing at a CAGR of 7.53% from 2024 to 2034.

North America is currently leading the gene overexpression cell line construction service market due to the increasing demand for biologics and the growth of specialized therapies.

The gene overexpression cell line construction service market includes six segments such as service type, expression system/ host cell type, gene delivery method, application, end user, and region.

Some key players include Thermo Fisher Scientific Inc., GenScript Biotech, Creative Biogene, Bio-Rad Laboratories, OriGene Technologies, Promega Corporation, etc.

FDA, WHO, NIH, ASGCT, ORIP, NIST, BGTC, AMP